Fisker Ocean SUV Drives Into Europe Today: Will Sagging Stock’s Fortunes Turn Around?
Fisker, Inc‘s (NYSE:FSR) moment of glory is within sight as the EV startup gears up to deliver the…
Peter Schiff Spots Great Divergence In Gold, Bank Stocks: ‘Old Fortunes Will Be Lost And New Fortunes Will Be Made’
Peter Schiff, chief economist and global strategist at Euro Pacific Capital, has highlighted the contrarian price movements in…
Apple Analyst Lauds ‘Lebron-Like’ March Quarter: ‘Cupertino A Key Barometer Of Overall Consumer Spending’
Apple, Inc. (NASDAQ:AAPL) reported a “Lebron-like” March quarter, with both top- and bottom-line beats, Wedbush analyst Daniel Ives…
Cramer Says Banking Stocks Turmoil Looks Like ‘Train Wreck’ For Wall Street — But Market Won’t Be Destroyed If Debt Ceiling Crisis Is Resolved
Market commentator Jim Cramer reportedly said the mayhem in bank stocks may feel like a looming “train wreck”…
Apple, Carvana, Coinbase, DraftKings, Block: Why These 5 Stocks Are Drawing Investors’ Attention Today
U.S. markets ended in the red on Thursday as concerns regarding the banking sector gained momentum following PacWest…
Apple Earnings Call Takeaways: Emerging Market Strength, Guarded AI Approach, Muted Q3 Guidance And More
Apple, Inc. (NASDAQ:AAPL) reported forecast-beating results for the fiscal year second quarter, thanks to stronger-than-expected iPhone sales and…
Apple Q2 Earnings Thump Estimates, Buoyed By Robust iPhone Sales, Record Services Revenue
Apple, Inc. (NASDAQ:AAPL) reported second-quarter results that exceeded expectations Thursday, in line with the positive earnings trend seen…
Analysts Raise The Roof With Boosted Price Targets For Builders Firstsource
Analysts are upbeat on the growth prospects of Builders FirstSource Inc (NYSE: BLDR) and raised the price target.
Cognex Clocks 29% Revenue Decline In Q1, Mirroring Broader Macroeconomic Softness
Cognex Corporation (NASDAQ:CGNX) reported a first-quarter FY23 revenue decline of 28.8% to $201.12 million, beating the consensus of $192.01 million.…
Alnylam Clocks ~50% Revenue Growth In Q1 On Solid Commercial Execution
Alnylam Pharmaceuticals, Inc. (NASDAQ:ALNY) reported first-quarter FY23 revenues of $319.29 million, up 49.7% year over year, beating the consensus of…